A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in Chinese by up-regulated miRNA-let-7a expression

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Xu, Qian ^a   Dong, Qiguan ^a   He, Caiyun ^a   Liu, Wenjing ^a   Sun, Liping ^a   Liu, Jingwei ^a   Xing, Chengzhong ^a   Li, Xiaohang ^a   Wang, Bengang ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA LET 7A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; STOMACH TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84899713851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095249     Document Type: Article

References (49)

1. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
2. Duan R, Pak C, Jin P (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16: 1124-1131. (Pubitemid 47062732)
3. Sarver AL, Li L, Subramanian S (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 70: 9570-9580.
4. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, et al. (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89.
5. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D (2003) MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol 13: 807-818. (Pubitemid 36573248)
6. Schuldt A (2010) Great expectations of small RNAs. Nat Rev Mol Cell Biol 11: 676.
7. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
8. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677. (Pubitemid 46676103)
9. Brookes AJ (1999) The essence of SNPs. Gene 234: 177-186.
10. Shastry BS (2009) SNPs: impact on gene function and phenotype. Methods Mol Biol 578: 3-22.
11. Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, et al. (2013) Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control 24: 1099-1109.
12. Xu Y, Liu L, Liu J, Zhang Y, Zhu J, et al. (2011) A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128: 412-417.
13. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, et al. (2007) Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2: e873.
14. Yang J, Zhou F, Xu T, Deng H, Ge YY, et al. (2008) Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas. Mutat Res 638: 205-209.
15. Zhou J, Peng R, Li T, Luo X, Peng H, et al. (2013) A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy. Gene 527: 456-461.
16. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841. (Pubitemid 29108856)
17. Long N, Moore MA, Chen W, Gao CM, Lai MS, et al. (2010) Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pac J Cancer Prev 11 Suppl 2: 107-148.
18. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, et al. (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9: 279-287. (Pubitemid 351722947)
19. Wang F, Sun GP, Zou YF, Fan LL, Song B (2013) Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk. Mol Biol Rep 40: 109-116.
20. Wu XJ, Mi YY, Yang H, Hu AK, Li C, et al. (2013) Association of the hsa-mir-499 (rs3746444) Polymorphisms with Gastric Cancer Risk in the Chinese Population. Onkologie 36: 573-576.
21. Zhou F, Zhu H, Luo D, Wang M, Dong X, et al. (2012) A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol 31: 1290-1295.
22. Mu YP, Su XL (2012) Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population. Med Oncol 29: 1723-1732.
23. Lauren P (1965) The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand 64: 31-49.
24. Xu Q, Chen MY, He CY, Sun LP, Yuan Y (2013) Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population. Gene 529: 104-112.
25. Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181.
26. Stolte M, Meining A (2001) The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol 15: 591-598. (Pubitemid 33062055)
27. Xu Q, Yuan Y, Sun LP, Gong YH, Xu Y, et al. (2009) Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol 35: 1313-1320.
28. Gong YH, Sun LP, Jin SG, Yuan Y (2010) Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis 29: 907-911.
29. Liu R, Zhang C, Hu Z, Li G, Wang C, et al. (2011) A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47: 784-791.
30. Chen PS, Su JL, Hung MC (2012) Dysregulation of microRNAs in cancer. J Biomed Sci 19: 90.
31. Fabbri M, Calore F, Paone A, Galli R, Calin GA (2013) Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol 754: 137-148.
32. Salzman DW, Weidhaas JB (2013) SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther 137: 55-63.
33. Fabbri M, Valeri N, Calin GA (2009) MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis 30: 912-917.
34. Srivastava K, Srivastava A (2012) Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 7: e50966.
35. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004. (Pubitemid 38327724)
36. Mishra PJ, Bertino JR (2009) MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10: 399-416.
37. Wang P, Xie S, Cui A, Zhang Y, Jiang B (2013) miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Exp Ther Med 3: 324-330.
38. Wang J, Bi J, Liu X, Li K, Di J, et al. (2013) Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol Biol Rep 39: 4571-4579.
39. Wang N, Tian ZQ, Li Y, Zhou RM, Wang GY (2013) An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis. Genet Mol Res 12: 3955-3964.
40. Zhang YG, Shi JX, Song CH, Wang P, Dai LP, et al. (2013) Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pac J Cancer Prev 14: 2337-2342.
41. Xu L, Zhou X, Qiu MT, Yin R, Wu YQ, et al. (2013) Lack of Association between Hsa-miR-149 rs2292832 Polymorphism and Cancer Risk: A Meta-Analysis of 12 Studies. PLoS One 8: e73762.
42. Xu Q, He CY, Liu JW, Yuan Y (2013) Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis. PLoS One 8: e65208.
43. Arisawa T, Tahara T, Shiroeda H, Matsue Y, Minato T, et al. (2012) Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer. Hum Immunol 73: 747-752.
44. Zhu YM, Zhong ZX, Liu ZM (2010) Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol 16: 3325-3329.
45. Wang WN, Chen Y, Zhang YD, Hu TH (2013) The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. Tumour Biol 34: 1865-1871.
46. Lao-Sirieix P, Caldas C, Fitzgerald RC (2010) Genetic predisposition to gastrooesophageal cancer. Curr Opin Genet Dev 20: 210-217.
47. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D (2004) Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 159: 252-258. (Pubitemid 38141654)
48. Tramacere I, Pelucchi C, Bagnardi V, Rota M, Scotti L, et al. (2012) A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol 23: 287-297.
49. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, et al. (2012) A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 23: 28-36.